Cargando…

Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor

Targeting DNA repair pathway offers an important therapeutic strategy for Homo sapiens (human) cancers. However, the failure of DNA repair inhibitors to markedly benefit patients necessitates the development of new strategies. Here, we show that exosome component 1 (EXOSC1) promotes DNA damages and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qiaoling, Xiao, Qi, Sun, Zhen, Wang, Bo, Wang, Lina, Wang, Na, Wang, Kai, Song, Chengli, Yang, Qingkai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260222/
https://www.ncbi.nlm.nih.gov/pubmed/34159897
http://dx.doi.org/10.7554/eLife.69454
_version_ 1783718780957884416
author Liu, Qiaoling
Xiao, Qi
Sun, Zhen
Wang, Bo
Wang, Lina
Wang, Na
Wang, Kai
Song, Chengli
Yang, Qingkai
author_facet Liu, Qiaoling
Xiao, Qi
Sun, Zhen
Wang, Bo
Wang, Lina
Wang, Na
Wang, Kai
Song, Chengli
Yang, Qingkai
author_sort Liu, Qiaoling
collection PubMed
description Targeting DNA repair pathway offers an important therapeutic strategy for Homo sapiens (human) cancers. However, the failure of DNA repair inhibitors to markedly benefit patients necessitates the development of new strategies. Here, we show that exosome component 1 (EXOSC1) promotes DNA damages and sensitizes human kidney renal clear cell carcinoma (KIRC) cells to DNA repair inhibitor. Considering that endogenous source of mutation (ESM) constantly assaults genomic DNA and likely sensitizes human cancer cells to the inhibitor, we first analyzed the statistical relationship between the expression of individual genes and the mutations for KIRC. Among the candidates, EXOSC1 most notably promoted DNA damages and subsequent mutations via preferentially cleaving C site(s) in single-stranded DNA. Consistently, EXOSC1 was more significantly correlated with C>A transversions in coding strands than these in template strands in human KIRC. Notably, KIRC patients with high EXOSC1 showed a poor prognosis, and EXOSC1 sensitized human cancer cells to poly(ADP-ribose) polymerase inhibitors. These results show that EXOSC1 acts as an ESM in KIRC, and targeting EXOSC1 might be a potential therapeutic strategy.
format Online
Article
Text
id pubmed-8260222
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-82602222021-07-07 Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor Liu, Qiaoling Xiao, Qi Sun, Zhen Wang, Bo Wang, Lina Wang, Na Wang, Kai Song, Chengli Yang, Qingkai eLife Cancer Biology Targeting DNA repair pathway offers an important therapeutic strategy for Homo sapiens (human) cancers. However, the failure of DNA repair inhibitors to markedly benefit patients necessitates the development of new strategies. Here, we show that exosome component 1 (EXOSC1) promotes DNA damages and sensitizes human kidney renal clear cell carcinoma (KIRC) cells to DNA repair inhibitor. Considering that endogenous source of mutation (ESM) constantly assaults genomic DNA and likely sensitizes human cancer cells to the inhibitor, we first analyzed the statistical relationship between the expression of individual genes and the mutations for KIRC. Among the candidates, EXOSC1 most notably promoted DNA damages and subsequent mutations via preferentially cleaving C site(s) in single-stranded DNA. Consistently, EXOSC1 was more significantly correlated with C>A transversions in coding strands than these in template strands in human KIRC. Notably, KIRC patients with high EXOSC1 showed a poor prognosis, and EXOSC1 sensitized human cancer cells to poly(ADP-ribose) polymerase inhibitors. These results show that EXOSC1 acts as an ESM in KIRC, and targeting EXOSC1 might be a potential therapeutic strategy. eLife Sciences Publications, Ltd 2021-06-23 /pmc/articles/PMC8260222/ /pubmed/34159897 http://dx.doi.org/10.7554/eLife.69454 Text en © 2021, Liu et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Cancer Biology
Liu, Qiaoling
Xiao, Qi
Sun, Zhen
Wang, Bo
Wang, Lina
Wang, Na
Wang, Kai
Song, Chengli
Yang, Qingkai
Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor
title Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor
title_full Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor
title_fullStr Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor
title_full_unstemmed Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor
title_short Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor
title_sort exosome component 1 cleaves single-stranded dna and sensitizes human kidney renal clear cell carcinoma cells to poly(adp-ribose) polymerase inhibitor
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260222/
https://www.ncbi.nlm.nih.gov/pubmed/34159897
http://dx.doi.org/10.7554/eLife.69454
work_keys_str_mv AT liuqiaoling exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor
AT xiaoqi exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor
AT sunzhen exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor
AT wangbo exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor
AT wanglina exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor
AT wangna exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor
AT wangkai exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor
AT songchengli exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor
AT yangqingkai exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor